Mapping Of Nucleocapsid Protein (Np) Epitopes and Np-Phosphoprotein Interactive Domains of Newcastle Disease Virus with Np Monoclonal Antibodies by Ahmad Raus, Raha
  
 
UNIVERSITI PUTRA MALAYSIA 
 
 
 
 
MAPPING OF NUCLEOCAPSID PROTEIN (NP) EPITOPES AND NP-
PHOSPHOPROTEIN (P) INTERACTIVE DOMAINS OF NEWCASTLE 
DISEASE VIRUS WITH NP MONOCLONAL ANTIBODIES 
 
 
 
 
RAHA AHMAD RAUS 
 
 
 
IB 2006 8 
 
MAPPING OF NUCLEOCAPSID PROTEIN (NP) 
EPITOPES AND NP-PHOSPHOPROTEIN 
INTERACTIVE DOMAINS OF NEWCASTLE 
DISEASE VIRUS WITH NP MONOCLONAL 
ANTIBODIES 
 
 
 
 
 
 
 
 
 
RAHA AHMAD RAUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOCTOR OF PHILOSOPHY 
UNIVERSITI PUTRA MALAYSIA 
 
2006 
 
MAPPING OF NUCLEOCAPSID PROTEIN (NP) EPITOPES AND NP-
PHOSPHOPROTEIN (P) INTERACTIVE DOMAINS OF NEWCASTLE 
DISEASE VIRUS WITH NP MONOCLONAL ANTIBODIES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      By 
 
RAHA AHMAD RAUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, 
in Fulfilment of the Requirement for the Degree of Doctor of Philosophy 
 
October 2006 
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfillment 
of the requirement for the degree of Doctor of Philosophy 
 
MAPPING OF NUCLEOCAPSID PROTEIN (NP) EPITOPES AND NP-
PHOSPHOPROTEIN INTERACTIVE DOMAINS OF NEWCASTLE 
DISEASE VIRUS WITH NP MONOCLONAL ANTIBODIES 
 
By 
 
RAHA AHMAD RAUS 
 
October 2006 
 
Chairman : Professor Datin Khatijah Mohd. Yusoff, PhD 
 
Institute : Bioscience 
 
 
The Newcastle disease virus (NDV) is an economically important poultry virus which 
replicates in certain human cancer cells. This virus contains a negative single stranded 
RNA genome which encodes for the nucleocapsid protein (NP), phosphorylated 
nucleocapsid-associated protein, phosphoprotein (P); matrix protein (M); fusion 
protein (F); haemaglutinin-neuraminidase protein (HN) and the RNA-directed RNA 
polymerase, large protein (L). 
  
The NP is the most abundant protein found in NDV. In this study, a panel of 
monoclonal antibodies (mAbs) against NP was developed to study the NP-P 
interactions in NDV. The spleen cells of Balb/C mice immunized with purified NP 
obtained from the velogenic NDV strain AF2240 were fused with myeloma cells 
(Sp2/0-Ag14 cell line). A panel of six mAbs were produced and characterized.  Four 
of the mAbs secreted immunoglobulins from class IgG2a with kappa light chains and 
the remaining two were from class IgG1 with kappa light chains. Cross-reactivity test 
against the NPs from other six NDV strains showed that mAbs, a2, a2s and b2 cross-
reacted with all NDV strains, while mAb b3 showed specificity towards the NP of 
 ii
strain AF2240, the strain that was used earlier to immunize the mice. The other two 
mAbs, b4s and c1, demonstrated cross-reactivity amongst the various viral strains 
with varying reactivities. These results indicate that certain epitopes recognized by the 
mAbs were well conserved in all NDV strains whilst the other epitopes may have 
undergone some structural changes. 
  
The antigenic sites of NP bound by the mAbs were localized by Western blot 
analysis. Four C- and N-terminally truncated NP mutants were purified from 
Escherichia coli, blotted to the nitrocellulose membrane and probed with NP mAbs. 
The results show that the antigenic sites bound by mAbs a2, a2s and b2 were located 
within amino acids 441 to 489 of the C-terminal of NP. On the other hand, antigenic 
sites that were recognized by the mAbs, b3 and b4s were located on the N-terminal 
half of NP from 26 to 121 amino acid residues. MAb c1 bound to all C- and N-
truncated mutants indicating that the antigenic sites recognized by mAb c1 may be 
located within amino acids 122 to 375. 
     
One of the mAb, a2s was further used as a tool in protein-protein interaction study 
between assembled NP (NPNC) and P. The NPNC was purified from E. coli by 
ammonium sulphate precipitation and sucrose garadient. In determining the 
interaction regions of P that bind to NPNC, the mAb is used in immunoprecipitating 
the radioactively labeled Ps-NPNC complex. The failure of certain P deleted mutants to 
form complex with NPNC demonstrated that the regions of P which were deleted from 
those mutants were responsible with the binding to NPNC. After 18 different N- and C-
terminally truncated P mutants were tested in the radioimmunoprecipitation assay, it 
showed that the region of P that binds to NPNC is located within the internal region of 
 iii
C-terminal half of P, from amino acids 243 to279. In agreement with the 
radioimmunoprecipitation results, protein binding assay, another assay that was 
carried out to determine the P-NPNC interactive domain also showed that the 
interactive domain was mapped to the internal region of the C-terminal half of P 
(amino acids 224-279). A slightly bigger region of interaction domain was determined 
by the latter assay compared to the former assay was due to its nature and higher 
sensitivity of the assay. Nevertheless, both assays showed that the N-terminal half and 
immediate C-terminal end of P is not involved in the binding of P to NPNC.  
 
To further explore the interactions between P and NP, Far Western blotting was 
carried out to determine the binding domain of P to NP monomer, NPO. The NPO was 
obtained by fractionating the NPNC in SDS-PAGE. In this assay, the same deleted 
mutants that are utilized in mapping P-NPNC interactive domain were also used. The 
assay showed that amino acids 224-279 were indispensable for the P-NPO binding.  
Interestingly, these were the same amino acids that were responsible for the P-NPNC 
interaction. These results indicate that these amino acids were crucial for interaction 
between P and NP and may play bigger roles in transcription and replication of viral 
genome.  
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Virus penyakit Newcastle (NDV) adalah virus yang menyebabkan kerugian dalam 
industri ternakan ayam dan juga boleh bereplikasi dalam sel kanser manusia tertentu. 
Ia mengandungi genom bebenang tunggal (negatif) RNA yang mengkodkan protein 
nukleokapsid (NP), protein fosforilasi yang bertuapan dengan nukleokapsid, 
fosfoprotein (P), protein matriks (M), protein tuapan (F), protein hemaglutinin-
neuraminidas (HN) dan polimeras RNA, protein besar (L).   
 
NP merupakan protein yang boleh didapati dengan banyak dalam NDV. Dalam kajian 
ini, satu panel monoclonal antibodi (mAb) terhadap NP telah dihasilkan untuk 
digunakan dalam kajian interaksi NP-P NDV. Sel limpa mencit Balb/C yang 
diimunisasi dengan NP yang diperolehi daripada NDV veliogenik strain AF 2240 
telah digabungkan dengan sel miloma (sel Sp2/0-Ag14). Satu panel yang terdiri 
daripada enam mAb telah dihasilkan dan dicirikan. Empat daripada mAb tersebut 
merembeskan immunoglobulin daripada kelas IgG2 dengan rantai ringan kappa dan 
dua lagi daripada kelas IgG1 dengan rantai ringan kappa. Ujian reaksi silang terhadap 
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NP daripada enam strain NDV lain menunjukkan  mAbs a2, a2s dan b2 bereaksi 
silang dengan semua strain NDV, manakala mAb b3 menunjukkan spesifisiti terhadap 
NP strain AF2240 iaitu strain sama yang digunakan untuk imunisasi mencit. Dua lagi 
mAb iaitu b4s dan c1 menunjukkan reaksi silang secara variasi terhadap semua strain 
tersebut. Keputusan ini menunjukkan terdapat epitop tertentu yang dikenalpasti oleh 
mAb adalah terpelihara dalam semua strain NDV manakala epitop lain telah 
mengalami perubahan struktur. 
  
Tapak antigenik NP yang dikenalpasti oleh mAb telah diidentifikasi dengan analisis 
blot Western. Empat mutan NP yang terpotong pada terminal-C and -N yang 
diekstrak daripada Escherichia coli diblot kepada membran nitroselulosa dan diprob 
dengan mAb NP. Keputusan menunjukkan tapak antigenik yang dikenalpasti oleh 
mAb a2, a2s dan b2 terletak pada asid amino 441 hingga 489 terminal-C NP. 
Manakala tapak antigenik yang dikenalpasti oleh mAb b3 dan b4s terletak pada 
terminal-N NP dari asid amino 26 hingga 121. MAb c1 melekat pada semua mutan 
NP yang terpotong pada terminal-C and –N dan ini menunjukkan tapak antigenik 
yang dikenalpasti oleh mAb c1 terletak pada asid amino 122 hingga 375. 
             
Satu daripada mAb iaitu a2s telah digunakan dalam kajian interaksi antara NP yang 
berhimpun, NPNC dan P. NPNC diekstrak daripada E. coli dengan kaedah presipitasi 
ammonium sulphate and gradien sukros. Dalam menentukan domain interaksi P yang 
bergabung kepada NPNC, mAb tersebut digunakan untuk immunopresipitat pelbagai 
kompleks mutan P-NPNC yang dilabel dengan radioaktif. Selepas 18 mutan P yang 
terpotong pada terminal-C and –N diuji dengan asai radioimmunopresipitasi, 
keputusan menunjukkan domain P yang bergabung dengan NPNC adalah terletak 
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dalam bahagian dalaman terminal-C iaitu daripada asid amino 243 sehinnga 279. Asai 
gabung protein juga meunjukkan domain P yang bergabung kepada NPNC adalah 
terletak pada bahagian yang sama (asid amino 224-279). Domain interaksi yang 
diidentifikasi oleh asai gabung protein adalah lebih besar daripada asai 
radioimunopresipitasi adalah disebabkan bentuk tafsiran asai gabung protein yang 
lebih sensitif berbanding asai imunopresipitasi. Walau bagaimanapun, kedua-dua asai 
menunjukkan terminal-N dan hujung terminal-C P tidak terlibat dalam interaksi P 
kepada NPNC.  
 
Untuk mendalami kajian interaksi P dan NP, blot Western Far telah digunakan dalam 
mengenalpasti domain P yang bergabung dengan monomer NP, NPO. NPO diperolehi 
dengan fraksinasi NPNC di dalam SDS-PAGE. Dalam asai ini, mutan P yang sama 
yang telah digunakan dalam kajian interaksi P-NPNC telah digunakan. Asai tersebut 
menunjukkan asid amino 224 sehingga 279 adalah terlibat dalam interaksi P-NPO. 
Yang menariknya, asid amino tersebut juga terlibat dalam interaksi P-NPNC. Ini 
menunjukkan asid amino tersebut sangat penting dalam interaksi P-NP dan 
kemungkinan memainkan peranan lebih besar dalam transkripsi dan replikasi genom 
virus.   
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 CHAPTER 1 
INTRODUCTION 
 
One of the immune responses to eliminate pathogens and other foreign molecules 
from our body is by secreting antibodies that act specifically against them. Antibodies 
are produced in large quantities by plasma cells which are developed from precursor 
B cells. However, Kohler and Milstein (1975) successfully produced the antibodies in 
vitro through permanent tissue culture cell lines. These antibodies are produced by 
hybridoma cells which are generated from a fusion of immunized B-cells and 
myeloma tumor cells. These antibodies are considered monoclonal (mAb) as they are 
secreted from a single cell or clone. Therefore these antibodies are specific against a 
particular epitope of an antigen. Although initially, these mAbs which were produced 
had no practical application, further investigations by other scientists have resulted in 
many beneficial discoveries. At present, the production of mAbs has resulted in the 
generation of an industry with an economic impact measured in billions of dollars.  
 
MAbs with specificity to tumour-associated antigens have been applied in various 
diagnostic assays in vitro and as well as in vivo by using gamma-emitting radio-
labelled mAbs to identify the location of tumor in patient. It has also been used to 
treat cancerous and non-cancerous diseases and act as a carrier to various toxin, 
cytostatic drug and radionuclides to treat diseases (Govindan et al., 2005). Poisoning 
with digoxin and other potent, low formula mass poisons, such as colchicine and 
tricyclic antidepressants could be successfully treated using specific mAbs fragment, 
Fab (Flanagan and Jones, 2004). Identification of bacteria, virus and protozoa in 
clinical samples are easily conducted by using mAbs that are specific against each 
microbe. For certain bacterial and viral infections, the use of neutralizing mAbs 
confers impressive protection against the pathogen (Mc Cann et al., 2005). 
 
Other than its obvious contribution in clinical medicine, the use of mAbs has a strong 
impact towards the knowledge of biological sciences. For example, in neuroscience 
research, mAbs provide purified membrane associated proteins such as pumps, 
channels, receptors and cell-adhesion molecules so that their structures could be 
studied at high resolution. MAbs to cytoskeletal proteins, organelles, and protein 
kinases have revealed that specific molecules are concentrated in anatomically distinct 
regions of the cell and protein kinase has been shown to be a major postsynaptic 
constituent in many synapses. The antibodies are also used to identify functionally 
related subpopulations of neurons and describing neural cell lineages (Valentino et 
al., 1985).  
 
In the present study, mAbs are produced using the hybridoma technology. These were 
then characterized and, used to map the NP antigenic sites and to study protein-
protein interactions in Newcastle disease virus (NDV). This particular virus infects 
many avian species. In many countries worldwide, NDV infections result in great 
economic loses amounting billions of dollars as infections of chicken with velogenic 
strain of NDV causes up to 100% mortality. NDV contains a negative single stranded 
RNA genome which encodes at least six structural proteins, the nucleocapsid (NP), 
phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuraminidase (HN) and 
large polymerase (L) proteins. Among these proteins, the NP, P and L proteins are 
involved in viral transcription and replication. The interaction between P and NP is 
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